In contrast to the decrease in the numbers of CD14−/low/CD16+ monocytes from patients with ALS, the frequency of CD14−/low/CD16+/TIM-3+ monocytes was increased in both PBMC and isolated pan-monocytes from fast progressing patients. Here, CD14 is linked to amyotrophic lateral sclerosis.